Literature DB >> 2902632

Subunit S1 of pertussis toxin: mapping of the regions essential for ADP-ribosyltransferase activity.

M Pizza1, A Bartoloni, A Prugnola, S Silvestri, R Rappuoli.   

Abstract

The toxicity of pertussis toxin is mediated by the ADP-ribosyltransferase activity of subunit S1. To understand the structure-function relationship of subunit S1 and guide the construction of nontoxic molecules suitable for vaccines, we constructed and expressed in Escherichia coli a series of amino-terminal and carboxyl-terminal deletion mutants as well as a number of molecules containing amino acid substitutions. The shortest peptide still retaining enzymatic activity contains amino acids 2-179. Within this region we identified three mutants in which amino acid substitutions abolish the enzymatic activity. Mutation of amino acids 8 and 9 or 50 and 53, located within the region of the S1 subunit of pertussis toxin homologous to cholera toxin, causes loss of enzymatic activity. Outside this homology region, substitution of Glu-129 with glycine or aspartic acid also eliminates the enzymatic activity of the S1 subunit. In this respect, Glu-129 resembles the glutamic acid that is crucial for the catalytic activity of diphtheria and Pseudomonas toxins. Once introduced into the Bordetella pertussis chromosome, the above mutations should lead to the synthesis of nontoxic pertussis toxin molecules suitable for vaccine production.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2902632      PMCID: PMC282223          DOI: 10.1073/pnas.85.20.7521

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

1.  ADP-ribosylation of transducin by pertussis toxin blocks the light-stimulated hydrolysis of GTP and cGMP in retinal photoreceptors.

Authors:  C Van Dop; G Yamanaka; F Steinberg; R D Sekura; C R Manclark; L Stryer; H R Bourne
Journal:  J Biol Chem       Date:  1984-01-10       Impact factor: 5.157

2.  The amino-acid sequence of two non-toxic mutants of diphtheria toxin: CRM45 and CRM197.

Authors:  G Giannini; R Rappuoli; G Ratti
Journal:  Nucleic Acids Res       Date:  1984-05-25       Impact factor: 16.971

3.  NAD binding site of diphtheria toxin: identification of a residue within the nicotinamide subsite by photochemical modification with NAD.

Authors:  S F Carroll; R J Collier
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

4.  Monoclonal antibody against pertussis toxin: effect on toxin activity and pertussis infections.

Authors:  H Sato; A Ito; J Chiba; Y Sato
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

5.  Oligonucleotide-directed mutagenesis: a simple method using two oligonucleotide primers and a single-stranded DNA template.

Authors:  M J Zoller; M Smith
Journal:  DNA       Date:  1984-12

6.  Nucleotide sequence of the structural gene for diphtheria toxin carried by corynebacteriophage beta.

Authors:  L Greenfield; M J Bjorn; G Horn; D Fong; G A Buck; R J Collier; D A Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

7.  Amino acid sequence homology between the enzymic domains of diphtheria toxin and Pseudomonas aeruginosa exotoxin A.

Authors:  S F Carroll; R J Collier
Journal:  Mol Microbiol       Date:  1988-03       Impact factor: 3.979

Review 8.  Bacterial toxins: cellular mechanisms of action.

Authors:  J L Middlebrook; R B Dorland
Journal:  Microbiol Rev       Date:  1984-09

9.  Cloning, nucleotide sequence, and expression in Escherichia coli of the exotoxin A structural gene of Pseudomonas aeruginosa.

Authors:  G L Gray; D H Smith; J S Baldridge; R N Harkins; M L Vasil; E Y Chen; H L Heyneker
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 12.779

10.  Toxoids of Pseudomonas aeruginosa toxin A: production by chemical and genetic means.

Authors:  S J Cryz; B H Iglewski
Journal:  Rev Infect Dis       Date:  1983 Nov-Dec
View more
  39 in total

1.  Expression of a C terminally truncated form of pertussis toxin S1 subunit effectively induces protection against pertussis toxin following DNA-based immunization.

Authors:  Kazunari Kamachi; Yoshichika Arakawa
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

2.  Engineering of genetically detoxified pertussis toxin analogs for development of a recombinant whooping cough vaccine.

Authors:  S M Loosmore; G R Zealey; H A Boux; S A Cockle; K Radika; R E Fahim; G J Zobrist; R K Yacoob; P C Chong; F L Yao
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

3.  Properties of the B oligomer of pertussis toxin.

Authors:  L Nencioni; M G Pizza; G Volpini; M T De Magistris; F Giovannoni; R Rappuoli
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

4.  Site-specific mutagenesis of the catalytic subunit of cholera toxin: substituting lysine for arginine 7 causes loss of activity.

Authors:  W N Burnette; V L Mar; B W Platler; J D Schlotterbeck; M D McGinley; K S Stoney; M F Rohde; H R Kaslow
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

5.  Neutralizing antibodies and immunoprotection against pertussis and tetanus obtained by use of a recombinant pertussis toxin-tetanus toxin fusion protein.

Authors:  P Boucher; H Sato; Y Sato; C Locht
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

6.  Biochemical and biological activities of recombinant S1 subunit of pertussis toxin.

Authors:  J T Barbieri; M Pizza; G Cortina; R Rappuoli
Journal:  Infect Immun       Date:  1990-04       Impact factor: 3.441

7.  Antibodies recognizing protective pertussis toxin epitopes are preferentially elicited by natural infection versus acellular immunization.

Authors:  Jamie N Sutherland; Christine Chang; Sandra M Yoder; Michael T Rock; Jennifer A Maynard
Journal:  Clin Vaccine Immunol       Date:  2011-04-20

8.  Monoclonal antibodies that inhibit ADP-ribosyltransferase but not NAD-glycohydrolase activity of pertussis toxin.

Authors:  H R Kaslow; J D Schlotterbeck; J G Kenimer
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

9.  Roles of the disulfide bond and the carboxy-terminal region of the S1 subunit in the assembly and biosynthesis of pertussis toxin.

Authors:  R Antoine; C Locht
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

10.  Effects of mutations on enzyme activity and immunoreactivity of the S1 subunit of pertussis toxin.

Authors:  Y Lobet; W Cieplak; S G Smith; J M Keith
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.